Aster Research Development vs Selling And Marketing Expenses Analysis

ASTERDM Stock

432.30 4.15 0.97%

Aster DM financial indicator trend analysis is way more than just evaluating Aster DM Healthcare prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aster DM Healthcare is a good investment. Please check the relationship between Aster DM Research Development and its Selling And Marketing Expenses accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aster DM Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Research Development vs Selling And Marketing Expenses

Research Development vs Selling And Marketing Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aster DM Healthcare Research Development account and Selling And Marketing Expenses. At this time, the significance of the direction appears to have very week relationship.

The correlation between Aster DM's Research Development and Selling And Marketing Expenses is 0.23. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Selling And Marketing Expenses in the same time period over historical financial statements of Aster DM Healthcare, assuming nothing else is changed. The correlation between historical values of Aster DM's Research Development and Selling And Marketing Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Aster DM Healthcare are associated (or correlated) with its Selling And Marketing Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling And Marketing Expenses has no effect on the direction of Research Development i.e., Aster DM's Research Development and Selling And Marketing Expenses go up and down completely randomly.

Correlation Coefficient

0.23

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Research Development

Selling And Marketing Expenses

Most indicators from Aster DM's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aster DM Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aster DM Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

As of the 24th of November 2024, Issuance Of Capital Stock is likely to grow to about 6.4 M, while Selling General Administrative is likely to drop about 4.8 B.

	2021	2022	2023	2024 (projected)
Gross Profit	73.4B	84.0B	27.8B	46.8B
Total Revenue	102.5B	119.3B	37.0B	71.3B

Gross Profit Total Revenue

Aster DM fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock
Total Assets		0.68	0.46	0.72	0.95	0.8	0.71	0.32	0.63	-0.03	0.79	0.69	0.46	0.06	0.42	0.57	0.82	0.74	0.5	0.53	0.4	0.99	0.67	0.57	0.67	0.83
Short Long Term Debt Total	0.68		-0.23	0.11	0.66	0.94	0.98	-0.14	0.9	0.33	0.94	0.54	0.52	0.43	0.86	0.94	0.66	0.96	0.92	-0.14	0.27	0.67	0.04	0.9	0.94	0.61
Other Current Liab	0.46	-0.23		0.94	0.37	0.03	-0.19	0.57	-0.25	-0.42	0.02	0.28	0.03	-0.51	-0.5	-0.39	0.37	-0.01	-0.47	0.98	0.1	0.48	0.96	-0.33	-0.23	0.35
Total Current Liabilities	0.72	0.11	0.94		0.63	0.37	0.15	0.56	0.08	-0.3	0.36	0.47	0.22	-0.36	-0.2	-0.06	0.62	0.32	-0.14	0.96	0.23	0.72	1.0	0.0	0.1	0.57
Total Stockholder Equity	0.95	0.66	0.37	0.63		0.82	0.74	0.36	0.68	0.04	0.82	0.63	0.53	0.05	0.51	0.64	0.79	0.69	0.58	0.42	0.53	0.89	0.59	0.65	0.72	0.8
Property Plant And Equipment Net	0.8	0.94	0.03	0.37	0.82		0.96	0.11	0.9	0.29	1.0	0.59	0.57	0.33	0.75	0.89	0.79	0.96	0.85	0.12	0.39	0.77	0.3	0.84	0.94	0.72
Net Debt	0.71	0.98	-0.19	0.15	0.74	0.96		-0.06	0.9	0.27	0.96	0.5	0.56	0.33	0.84	0.95	0.66	0.93	0.93	-0.09	0.31	0.68	0.08	0.93	0.96	0.61
Retained Earnings	0.32	-0.14	0.57	0.56	0.36	0.11	-0.06		0.06	0.22	0.08	-0.22	-0.38	-0.17	-0.39	-0.2	0.11	-0.05	-0.16	0.57	-0.15	0.27	0.57	-0.06	0.06	0.08
Accounts Payable	0.63	0.9	-0.25	0.08	0.68	0.9	0.9	0.06		0.55	0.9	0.41	0.33	0.6	0.77	0.9	0.55	0.86	0.93	-0.2	0.38	0.59	0.01	0.83	0.98	0.51
Cash	-0.03	0.33	-0.42	-0.3	0.04	0.29	0.27	0.22	0.55		0.29	-0.12	-0.21	0.76	0.33	0.39	0.02	0.28	0.47	-0.45	0.03	-0.07	-0.33	0.35	0.46	0.09
Non Current Assets Total	0.79	0.94	0.02	0.36	0.82	1.0	0.96	0.08	0.9	0.29		0.62	0.6	0.35	0.76	0.89	0.8	0.97	0.85	0.11	0.42	0.76	0.29	0.84	0.94	0.73
Non Currrent Assets Other	0.69	0.54	0.28	0.47	0.63	0.59	0.5	-0.22	0.41	-0.12	0.62		0.76	0.29	0.52	0.5	0.83	0.63	0.41	0.29	0.62	0.7	0.44	0.39	0.42	0.83
Other Assets	0.46	0.52	0.03	0.22	0.53	0.57	0.56	-0.38	0.33	-0.21	0.6	0.76		0.05	0.64	0.62	0.71	0.56	0.45	0.07	0.64	0.42	0.19	0.47	0.41	0.7
Cash And Short Term Investments	0.06	0.43	-0.51	-0.36	0.05	0.33	0.33	-0.17	0.6	0.76	0.35	0.29	0.05		0.46	0.5	0.17	0.39	0.56	-0.54	0.2	0.06	-0.4	0.31	0.49	0.2
Net Receivables	0.42	0.86	-0.5	-0.2	0.51	0.75	0.84	-0.39	0.77	0.33	0.76	0.52	0.64	0.46		0.94	0.55	0.76	0.91	-0.43	0.47	0.38	-0.25	0.88	0.8	0.54
Good Will	0.57	0.94	-0.39	-0.06	0.64	0.89	0.95	-0.2	0.9	0.39	0.89	0.5	0.62	0.5	0.94		0.6	0.86	0.96	-0.32	0.42	0.52	-0.13	0.91	0.94	0.59
Common Stock Shares Outstanding	0.82	0.66	0.37	0.62	0.79	0.79	0.66	0.11	0.55	0.02	0.8	0.83	0.71	0.17	0.55	0.6		0.79	0.48	0.42	0.56	0.81	0.58	0.5	0.59	0.89
Non Current Liabilities Total	0.74	0.96	-0.01	0.32	0.69	0.96	0.93	-0.05	0.86	0.28	0.97	0.63	0.56	0.39	0.76	0.86	0.79		0.82	0.07	0.33	0.74	0.25	0.8	0.89	0.7
Inventory	0.5	0.92	-0.47	-0.14	0.58	0.85	0.93	-0.16	0.93	0.47	0.85	0.41	0.45	0.56	0.91	0.96	0.48	0.82		-0.39	0.34	0.46	-0.21	0.93	0.95	0.44
Other Current Assets	0.53	-0.14	0.98	0.96	0.42	0.12	-0.09	0.57	-0.2	-0.45	0.11	0.29	0.07	-0.54	-0.43	-0.32	0.42	0.07	-0.39		0.04	0.55	0.97	-0.22	-0.16	0.38
Other Stockholder Equity	0.4	0.27	0.1	0.23	0.53	0.39	0.31	-0.15	0.38	0.03	0.42	0.62	0.64	0.2	0.47	0.42	0.56	0.33	0.34	0.04		0.34	0.22	0.23	0.36	0.53
Total Liab	0.99	0.67	0.48	0.72	0.89	0.77	0.68	0.27	0.59	-0.07	0.76	0.7	0.42	0.06	0.38	0.52	0.81	0.74	0.46	0.55	0.34		0.68	0.52	0.63	0.81
Total Current Assets	0.67	0.04	0.96	1.0	0.59	0.3	0.08	0.57	0.01	-0.33	0.29	0.44	0.19	-0.4	-0.25	-0.13	0.58	0.25	-0.21	0.97	0.22	0.68		-0.06	0.03	0.54
Short Term Debt	0.57	0.9	-0.33	0.0	0.65	0.84	0.93	-0.06	0.83	0.35	0.84	0.39	0.47	0.31	0.88	0.91	0.5	0.8	0.93	-0.22	0.23	0.52	-0.06		0.89	0.51
Intangible Assets	0.67	0.94	-0.23	0.1	0.72	0.94	0.96	0.06	0.98	0.46	0.94	0.42	0.41	0.49	0.8	0.94	0.59	0.89	0.95	-0.16	0.36	0.63	0.03	0.89		0.54
Common Stock	0.83	0.61	0.35	0.57	0.8	0.72	0.61	0.08	0.51	0.09	0.73	0.83	0.7	0.2	0.54	0.59	0.89	0.7	0.44	0.38	0.53	0.81	0.54	0.51	0.54

Click cells to compare fundamentals

Aster DM Account Relationship Matchups

Aster DM fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	124.4B	116.4B	125.5B	148.8B	179.9B	98.9B
Short Long Term Debt Total	56.0B	48.0B	49.1B	57.0B	13.8B	13.1B
Other Current Liab	131.3M	3.4B	3.4B	2.8B	105.5B	110.8B
Total Current Liabilities	37.2B	32.0B	35.6B	46.6B	112.9B	118.5B
Total Stockholder Equity	32.7B	33.7B	39.5B	44.5B	45.6B	28.5B
Property Plant And Equipment Net	65.7B	63.8B	66.4B	78.0B	30.5B	43.1B
Net Debt	54.5B	45.5B	45.6B	53.2B	12.7B	12.1B
Retained Earnings	(2.3B)	(990.6M)	4.1B	7.7B	9.4B	9.9B
Accounts Payable	12.9B	20.3B	21.2B	29.9B	4.6B	4.4B
Cash	1.5B	2.6B	3.4B	3.8B	1.1B	1.9B
Non Current Assets Total	83.4B	80.1B	84.5B	99.6B	38.3B	56.2B
Non Currrent Assets Other	4.3B	2.5B	3.6B	4.9B	4.9B	4.0B
Other Assets	4.6B	2.9B	3.9B	1.6B	1.8B	3.1B
Cash And Short Term Investments	1.7B	3.1B	4.2B	6.3B	1.2B	1.1B
Net Receivables	24.4B	21.1B	20.6B	23.9B	2.6B	2.5B
Good Will	10.7B	10.5B	10.9B	11.6B	2.6B	2.5B
Liabilities And Stockholders Equity	124.4B	116.4B	125.5B	148.8B	179.9B	98.9B
Non Current Liabilities Total	50.0B	46.1B	45.1B	53.7B	16.7B	30.4B
Inventory	9.6B	8.5B	10.3B	13.1B	1.4B	1.3B
Other Current Assets	29.6B	4.3B	6.0B	7.3B	136.6B	143.4B
Other Stockholder Equity	(2.7B)	22.0B	22.0B	22.1B	16.9B	18.2B
Total Liab	87.2B	78.1B	80.6B	100.2B	129.6B	65.6B
Total Current Assets	41.0B	36.3B	41.0B	49.2B	141.7B	148.7B
Accumulated Other Comprehensive Income	(19.7B)	7.7B	8.4B	9.8B	14.3B	15.0B
Short Term Debt	12.6B	8.0B	10.1B	12.5B	2.5B	2.3B
Intangible Assets	2.2B	2.5B	2.8B	3.7B	313.8M	298.1M
Common Stock	5.1B	5.0B	5.0B	5.0B	5.7B	4.8B
Other Liab	6.2B	6.6B	5.8B	5.7B	6.5B	5.9B
Net Tangible Assets	22.5B	19.9B	20.7B	25.9B	29.8B	17.9B
Current Deferred Revenue	11.5B	3.8B	4.5B	2.4B	270.2M	256.7M
Long Term Debt	18.9B	17.5B	14.7B	13.1B	4.5B	4.2B
Short Term Investments	223.2M	477.6M	780.6M	2.5B	283.4M	269.2M
Deferred Long Term Liab	359.9M	333.7M	110.3M	70.9M	63.8M	60.6M
Short Long Term Debt	11.2B	1.6B	7.3B	9.8B	2.2B	2.1B
Property Plant Equipment	65.7B	63.8B	66.4B	78.0B	89.7B	51.4B
Long Term Debt Total	43.4B	40.3B	39.4B	44.7B	51.4B	34.1B
Capital Surpluse	22.1B	22.0B	22.0B	22.2B	25.5B	21.8B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Other Information on Investing in Aster Stock

Balance Sheet is a snapshot of the financial position of Aster DM Healthcare at a specified time, usually calculated after every quarter, six months, or one year. Aster DM Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Aster DM and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Aster currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aster Research Development vs Selling And Marketing Expenses Analysis

Research Development vs Selling And Marketing Expenses

Research Development vs Selling And Marketing Expenses Correlation Analysis

Correlation Coefficient

Research Development

Selling And Marketing Expenses

Aster DM fundamental ratios Correlations

Aster DM Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Aster DM fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Aster Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Current Liabilities
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Liab	+ 0.99	Total Assets
Net Debt	+ 0.98	Short Long Term Debt Total
Other Current Assets	+ 0.98	Other Current Liab
Intangible Assets	+ 0.98	Accounts Payable

Other Current Assets	- 0.54	Cash And Short Term Investments
Cash And Short Term Investments	- 0.51	Other Current Liab
Net Receivables	- 0.5	Other Current Liab
Inventory	- 0.47	Other Current Liab
Other Current Assets	- 0.45	Cash
Other Current Assets	- 0.43	Net Receivables